StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
17
Publishing Date
2023 - 10 - 26
1
2023 - 10 - 23
1
2023 - 08 - 30
1
2023 - 06 - 02
1
2022 - 11 - 10
1
2022 - 10 - 19
1
2022 - 10 - 13
1
2022 - 09 - 16
1
2022 - 09 - 01
1
2022 - 06 - 05
1
2022 - 04 - 14
1
2022 - 04 - 11
1
2021 - 11 - 25
1
2021 - 10 - 04
1
2021 - 09 - 20
1
2021 - 03 - 31
1
2020 - 12 - 21
1
Sector
Communications
1
Health technology
17
Tags
Africa
6
Agreement
4
Antibody
5
Approval
5
Authorization
14
Authorized
6
Biopharma
10
Biotech
4
Biotechnology
6
Bnt211
5
Business
4
Cancer
21
Candidate
12
Car-t
6
Ceo
4
Children
17
Chmp
8
Collaboration
15
Comirnaty®
13
Companies
11
Conference
7
Covid
61
Covid-19
50
Deadline
22
Designation
5
Earnings
18
Emergency use authorization
9
Europe
12
Fda
24
Financial
24
Financial results
10
Global
21
Growth
7
Health
6
Immunotherapy
9
License
6
Market
23
Merge
9
Mrna
14
N/a
296
Order
10
Pancreatic
8
Partnership
6
Pharm-country
5
Pharmaceutical
5
Phase 1
6
Positive
17
Program
8
Report
25
Research
20
Response
6
Results
52
Study
5
Submission
5
Therapeutics
15
Therapy
9
Trial
17
Update
27
Vaccine
111
Year
5
Entities
Biontech se
17
Orange
1
Pfizer, inc.
8
Sanofi
15
Symbols
ABBV
31
ADIL
10
ALNY
19
ALPMF
14
ALPMY
14
AMGN
14
ANVS
10
AQST
18
ARVL
21
AZN
13
BBIO
16
BGNE
19
BIIB
13
BMY
27
BNTX
17
BYSI
11
CHRS
21
CLDX
10
CLSD
15
DARE
13
FBIO
10
FNCTF
21
GILD
13
GSK
12
HOTH
14
IMMP
11
IMMX
10
INCY
15
IONS
21
IT
12
JNJ
46
LLY
30
LTUM
14
MDWD
11
MRK
19
MS
10
MYOV
10
NDAQ
42
NVS
19
NVSEF
15
PFE
45
PLRX
10
PPRUF
11
PPRUY
11
RCKT
11
RDHL
10
REGN
26
RGNX
17
RNAZ
10
SCYX
11
SLS
11
SNY
103
SNYNF
79
SRNE
19
TAK
14
TAYD
17
TEVJF
14
TNXP
12
VERU
10
VRTX
11
Exchanges
Nasdaq
17
Nyse
8
Crawled Date
2023 - 10 - 26
1
2023 - 10 - 23
1
2023 - 08 - 30
1
2023 - 06 - 02
1
2022 - 11 - 10
1
2022 - 10 - 19
1
2022 - 10 - 13
1
2022 - 09 - 16
1
2022 - 09 - 01
1
2022 - 06 - 05
1
2022 - 04 - 14
1
2022 - 04 - 11
1
2021 - 11 - 25
1
2021 - 10 - 04
1
2021 - 09 - 20
1
2021 - 03 - 31
1
2020 - 12 - 21
1
Crawled Time
08:00
1
11:00
5
12:20
1
13:00
1
14:00
2
15:00
2
15:20
1
15:30
1
16:00
1
17:00
1
20:20
1
Source
www.biospace.com
2
www.globenewswire.com
15
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Positive
symbols :
BNTX
save search
Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19
Published:
2023-10-26
(Crawled : 11:00)
- globenewswire.com
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-14.55%
|
O:
-0.39%
H:
2.48%
C:
1.8%
SNY
|
News
|
$47.15
1.84%
1.75%
2M
|
Health Technology
|
-12.84%
|
O:
0.09%
H:
0.0%
C:
0.0%
BNTX
|
News
|
$88.01
1.38%
1.36%
340K
|
Health Technology
|
-7.6%
|
O:
0.99%
H:
1.81%
C:
0.47%
covid-19
vaccine
positive
influenza
topline
program
BioNTech Presents Positive Phase 1/2 Data Update for CAR-T Cell Therapy Candidate BNT211 in Advanced Solid Tumors at ESMO Congress 2023
Published:
2023-10-23
(Crawled : 15:30)
- globenewswire.com
SNYNF
|
News
|
$92.7
-2.18%
77
|
Health Technology
|
-10.22%
|
O:
0.73%
H:
0.0%
C:
-0.48%
SNY
|
News
|
$47.15
1.84%
1.75%
2M
|
Health Technology
|
-11.6%
|
O:
-0.69%
H:
0.0%
C:
0.0%
BNTX
|
News
|
$88.01
1.38%
1.36%
340K
|
Health Technology
|
-3.19%
|
O:
-2.24%
H:
7.12%
C:
4.11%
bnt211
candidate
congress
tumors
positive
update
cell
car-t
therapy
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
Published:
2023-08-30
(Crawled : 14:00)
- globenewswire.com
SNY
|
News
|
$47.15
1.84%
1.75%
2M
|
Health Technology
|
-14.3%
|
O:
0.66%
H:
0.0%
C:
0.0%
BNTX
|
News
|
$88.01
1.38%
1.36%
340K
|
Health Technology
|
-28.19%
|
O:
0.05%
H:
0.0%
C:
0.0%
covid-19
chmp
vaccine
positive
BioNTech and OncoC4 Present Positive Phase 1/2 Data for Antibody Candidate BNT316/ONC-392 in Hard-to-Treat NSCLC at ASCO
Published:
2023-06-02
(Crawled : 11:00)
- globenewswire.com
SNYNF
|
News
|
$92.7
-2.18%
77
|
Health Technology
|
-8.59%
|
O:
-0.56%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.15
1.84%
1.75%
2M
|
Health Technology
|
-7.89%
|
O:
1.05%
H:
0.0%
C:
0.0%
BNTX
|
News
|
$88.01
1.38%
1.36%
340K
|
Health Technology
|
-15.47%
|
O:
3.21%
H:
2.0%
C:
0.62%
bnt316
candidate
antibody
asco
positive
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Children 5 Through 11 Years of Age in European Union
Published:
2022-11-10
(Crawled : 15:00)
- globenewswire.com
SNYNF
|
News
|
$92.7
-2.18%
77
|
Health Technology
|
4.39%
|
O:
-3.15%
H:
4.22%
C:
4.22%
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-43.79%
|
O:
1.72%
H:
0.47%
C:
-0.31%
SNY
|
News
|
$47.15
1.84%
1.75%
2M
|
Health Technology
|
6.77%
|
O:
3.05%
H:
0.0%
C:
0.0%
BNTX
|
News
|
$88.01
1.38%
1.36%
340K
|
Health Technology
|
-44.85%
|
O:
-4.59%
H:
3.28%
C:
3.06%
covid-19
chmp
children
vaccine
positive
Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 6 Months to less than 5 Years in the European Union
Published:
2022-10-19
(Crawled : 16:00)
- globenewswire.com
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-40.44%
|
O:
-0.41%
H:
0.36%
C:
-1.82%
SNY
|
News
|
$47.15
1.84%
1.75%
2M
|
Health Technology
|
14.09%
|
O:
-1.37%
H:
0.0%
C:
0.0%
BNTX
|
News
|
$88.01
1.38%
1.36%
340K
|
Health Technology
|
-34.16%
|
O:
-1.37%
H:
0.37%
C:
-6.97%
comirnaty
comirnaty®
chmp
children
positive
Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older
Published:
2022-10-13
(Crawled : 11:00)
- globenewswire.com
FNCTF
|
News
|
$11.16
1.13%
-20.84%
130
|
Communications
|
23.59%
|
O:
-4.1%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
77
|
Health Technology
|
20.5%
|
O:
-1.78%
H:
0.0%
C:
0.0%
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-37.52%
|
O:
-0.64%
H:
3.35%
C:
2.92%
SNY
|
News
|
$47.15
1.84%
1.75%
2M
|
Health Technology
|
16.94%
|
O:
-1.67%
H:
0.0%
C:
0.0%
BNTX
|
News
|
$88.01
1.38%
1.36%
340K
|
Health Technology
|
-35.59%
|
O:
-2.2%
H:
6.32%
C:
4.76%
trial
positive
Pfizer and BioNTech Receive Positive CHMP Opinion for Conversion of COMIRNATY® Conditional Marketing Authorization to Full Marketing Authorization in the European Union
Published:
2022-09-16
(Crawled : 12:20)
- globenewswire.com
SNYNF
|
News
|
$92.7
-2.18%
77
|
Health Technology
|
16.59%
|
O:
0.74%
H:
0.91%
C:
-0.74%
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-42.84%
|
O:
0.33%
H:
1.15%
C:
-0.13%
SNY
|
News
|
$47.15
1.84%
1.75%
2M
|
Health Technology
|
13.78%
|
O:
-0.52%
H:
0.0%
C:
0.0%
BNTX
|
News
|
$88.01
1.38%
1.36%
340K
|
Health Technology
|
-38.94%
|
O:
-1.82%
H:
3.27%
C:
3.0%
comirnaty
comirnaty®
chmp
authorization
positive
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union
Published:
2022-09-01
(Crawled : 14:00)
- globenewswire.com
SNYNF
|
News
|
$92.7
-2.18%
77
|
Health Technology
|
13.26%
|
O:
-4.51%
H:
1.07%
C:
1.07%
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-41.94%
|
O:
-0.2%
H:
3.35%
C:
3.3%
SNY
|
News
|
$47.15
1.84%
1.75%
2M
|
Health Technology
|
11.12%
|
O:
-3.04%
H:
0.45%
C:
0.05%
BNTX
|
News
|
$88.01
1.38%
1.36%
340K
|
Health Technology
|
-39.15%
|
O:
0.68%
H:
1.61%
C:
1.5%
covid-19
chmp
vaccine
positive
Positive Phase 1 Data from mRNA-based Individualized Neoantigen Specific Immunotherapy in Patients with Resected Pancreatic Cancer presented at ASCO
Published:
2022-06-05
(Crawled : 20:20)
- globenewswire.com
SNYNF
|
News
|
$92.7
-2.18%
77
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$47.15
1.84%
1.75%
2M
|
Health Technology
|
Email alert
Add to watchlist
BNTX
|
News
|
$88.01
1.38%
1.36%
340K
|
Health Technology
|
Email alert
Add to watchlist
immunotherapy
asco
positive
cancer
pancreatic
phase 1
Pfizer, BioNTech Seek Approval for Boosters in Children Following Positive Data
Published:
2022-04-14
(Crawled : 15:20)
- biospace.com/
BNTX
|
News
|
$88.01
1.38%
1.36%
340K
|
Health Technology
|
-50.94%
|
O:
-0.67%
H:
1.98%
C:
-1.62%
children
approval
positive
BioNTech Presents Positive Preliminary Phase 1/2 Data for First-in-Class CAR-T Program BNT211 at AACR
Published:
2022-04-11
(Crawled : 08:00)
- globenewswire.com
SNYNF
|
News
|
$92.7
-2.18%
77
|
Health Technology
|
-17.18%
|
O:
3.07%
H:
0.0%
C:
-0.32%
SNY
|
News
|
$47.15
1.84%
1.75%
2M
|
Health Technology
|
-16.46%
|
O:
4.5%
H:
0.0%
C:
0.0%
BNTX
|
News
|
$88.01
1.38%
1.36%
340K
|
Health Technology
|
-48.31%
|
O:
-2.44%
H:
3.61%
C:
2.68%
bnt211
car-t
program
positive
phase 1
Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 5 to under 12 Years of Age in the European Union
Published:
2021-11-25
(Crawled : 13:00)
- globenewswire.com
SNYNF
|
News
|
$92.7
-2.18%
77
|
Health Technology
|
Email alert
Add to watchlist
BNTX
|
News
|
$88.01
1.38%
1.36%
340K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$47.15
1.84%
1.75%
2M
|
Health Technology
|
Email alert
Add to watchlist
comirnaty
comirnaty®
europe
positive
chmp
children
Pfizer and BioNTech Receive CHMP Positive Opinion for COVID-19 Vaccine Booster in the European Union
Published:
2021-10-04
(Crawled : 17:00)
- globenewswire.com
SNY
|
News
|
$47.15
1.84%
1.75%
2M
|
Health Technology
|
-3.65%
|
O:
0.54%
H:
0.77%
C:
0.17%
BNTX
|
News
|
$88.01
1.38%
1.36%
340K
|
Health Technology
|
-65.46%
|
O:
-7.79%
H:
7.42%
C:
5.95%
covid
europe
positive
vaccine
chmp
covid-19
Pfizer and BioNTech Announce Positive Topline Results from Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years
Published:
2021-09-20
(Crawled : 11:00)
- globenewswire.com
SNY
|
News
|
$47.15
1.84%
1.75%
2M
|
Health Technology
|
-4.07%
|
O:
-1.35%
H:
0.0%
C:
0.0%
BNTX
|
News
|
$88.01
1.38%
1.36%
340K
|
Health Technology
|
-76.28%
|
O:
-8.02%
H:
3.64%
C:
-0.64%
covid
positive
results
topline
children
vaccine
trial
Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents
Published:
2021-03-31
(Crawled : 11:00)
- globenewswire.com
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-27.28%
|
O:
0.11%
H:
0.77%
C:
0.22%
SNY
|
News
|
$47.15
1.84%
1.75%
2M
|
Health Technology
|
-5.77%
|
O:
0.59%
H:
0.36%
C:
0.12%
BNTX
|
News
|
$88.01
1.38%
1.36%
340K
|
Health Technology
|
-15.73%
|
O:
4.81%
H:
1.4%
C:
-0.25%
covid
positive
results
topline
vaccine
covid-19
Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine
Published:
2020-12-21
(Crawled : 15:00)
- biospace.com/
PFE
|
News
A
|
$26.26
1.0%
0.38%
29M
|
Health Technology
|
-30.31%
|
O:
-1.06%
H:
0.32%
C:
0.27%
BNTX
|
News
|
$88.01
1.38%
1.36%
340K
|
Health Technology
|
-15.57%
|
O:
3.14%
H:
0.43%
C:
-0.98%
covid
vaccine
positive
chmp
covid-19
Gainers vs Losers
73%
27%
Top 10 Gainers
MTTR
|
News
M
|
$4.8
175.86%
63.6%
71M
|
AGBA
|
$2.5
100.0%
56.6%
200M
|
Finance
MLEC
|
$2.47
76.43%
42.62%
78M
|
n/a
NUWE
|
$0.334
29.96%
40.99%
2.5M
|
Manufacturing
EDBL
|
News
|
$6.26
66.49%
40.13%
16M
|
VIVK
|
$1.43
33.65%
27.7%
530K
|
Professional, Scientific, and T...
MNTS
|
$0.5
35.69%
26.3%
4.7M
|
SDIG
A
|
$3.64
35.32%
26.0%
990K
|
PROK
|
$2.72
33.33%
24.58%
2.6M
|
MIGI
|
$1.57
31.93%
24.2%
660K
|
Information
Your saved searches
Save your searches and get alerts when important news are released.